Chronic pain is a prevalent and complex condition where evidence continues to evolve around commonly prescribed therapies. This course discusses the latest systematic review comparing tramadol with placebo in adults with chronic pain, highlighting limited analgesic benefits and the balance of potential harms versus benefits that pharmacists should understand. You will gain evidence-based insights to guide medication review, patient counseling, and clinical decision-making in chronic pain management.
HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact
GUEST
Emma Murter, PharmD, MPH
Clinical Pharmacist, Intermountain Health
Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/
PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!
CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Summarize the current evidence on tramadol’s efficacy and safety profile in chronic pain based on placebo-controlled randomized trials.
2. Describe the clinical implications of recent tramadol evidence for pharmacist-led medication management in chronic pain care.
Rachel Maynard and Emma Murter have no relevant financial relationships to disclose.
0.05 CEU/0.5 Hr
UAN: 0107-0000-26-223-H01-P
Initial release date: 6/1/2026
Expiration date: 6/1/2027
Additional CPE details can be found here.
